Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
59.68
-4.54 (-7.07%)
At close: Jun 6, 2025, 4:00 PM
60.00
+0.32 (0.54%)
After-hours: Jun 6, 2025, 5:44 PM EDT

Belite Bio Statistics

Total Valuation

Belite Bio has a market cap or net worth of $1.94 billion. The enterprise value is $1.80 billion.

Market Cap 1.94B
Enterprise Value 1.80B

Important Dates

The last earnings date was Tuesday, May 13, 2025, after market close.

Earnings Date May 13, 2025
Ex-Dividend Date n/a

Share Statistics

Belite Bio has 32.54 million shares outstanding. The number of shares has increased by 8.22% in one year.

Current Share Class n/a
Shares Outstanding 32.54M
Shares Change (YoY) +8.22%
Shares Change (QoQ) +1.98%
Owned by Insiders (%) 1.40%
Owned by Institutions (%) 0.69%
Float 14.99M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 12.29
P/TBV Ratio 12.29
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 25.98

Current Ratio 25.98
Quick Ratio n/a
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2,359.25

Financial Efficiency

Return on equity (ROE) is -33.43% and return on invested capital (ROIC) is -23.17%.

Return on Equity (ROE) -33.43%
Return on Assets (ROA) -22.23%
Return on Invested Capital (ROIC) -23.17%
Return on Capital Employed (ROCE) -29.85%
Revenue Per Employee n/a
Profits Per Employee -$1.70M
Employee Count 25
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +22.57% in the last 52 weeks. The beta is -1.45, so Belite Bio's price volatility has been lower than the market average.

Beta (5Y) -1.45
52-Week Price Change +22.57%
50-Day Moving Average 61.58
200-Day Moving Average 60.58
Relative Strength Index (RSI) 41.69
Average Volume (20 Days) 32,559

Short Selling Information

Short Interest 89,702
Short Previous Month 72,906
Short % of Shares Out 0.60%
Short % of Float n/a
Short Ratio (days to cover) 3.63

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -47.19M
Pretax Income -31.62M
Net Income -42.55M
EBITDA -47.01M
EBIT -47.19M
Earnings Per Share (EPS) -$1.37
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt n/a
Net Cash n/a
Net Cash Per Share n/a
Equity (Book Value) 158.07M
Book Value Per Share 4.86
Working Capital 153.16M
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Belite Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -8.22%
Shareholder Yield -8.22%
Earnings Yield -2.19%
FCF Yield n/a

Analyst Forecast

The average price target for Belite Bio is $96.67, which is 61.98% higher than the current price. The consensus rating is "Strong Buy".

Price Target $96.67
Price Target Difference 61.98%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1